November 24, 2021
Video
HIV Stakeholders weigh on the future of PrEP.
November 22, 2021
Article
A study found trans people were not substantively included in many countries’ HIV national strategic plans, despite being disproportionately impacted by HIV/AIDS.
November 14, 2021
How 1 provider is training medical peers to offer PrEP education and prescribe it.
November 13, 2021
Bias against injection drug users can inhibit them from receiving potentially lifesaving care, such as HIV pre-exposure prophylaxis (PrEP). Community-based responses like syringe service programs help combat this stigma.
November 12, 2021
Fenway Health’s Pride in Our Health podcast is an example of new voices being heard, and an alternative means of getting health information to the general public.
November 11, 2021
Adding genotypic resistance testing (GRT) to routine care did not improve HIV virologic outcomes for patients for whom first-line ART failed, the study authors wrote.
November 10, 2021
Long-acting cabotegravir plus rilpivirine worked with or without a lead-in for ART-naïve HIV patients.
Social factors, such as stigma or support, strongly impacted adolescent girls and young women deciding to use HIV PrEP in Kenya and South Africa.
November 09, 2021
A new study looks at this population and what factors affect outcomes, including diagnosis. This is significant not only for pandemic response, but also preparedness for vulnerable patient populations.
November 08, 2021
People who inject drugs (PWID) remain at risk of HIV infection, according to a recent report by the CDC, which found HIV infection and HIV-associated behaviors remained steady between 2015 and 2018.
